We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GG
676
DELISTED
Goldcorp Inc
GG
$67.7M 0.01%
3,538,154
-1,804,010
-34% -$32M
MOG.A icon
677
Moog Inc Class A
MOG.A
$13.6B
$67.4M 0.01%
1,250,787
+305,730
+32% +$15.5M
MATX icon
678
Matsons
MATX
$6.41B
$66.9M 0.01%
2,072,371
+742,580
+56% +$25.7M
HDB icon
679
HDFC Bank
HDB
$119B
$66.7M 0.01%
4,020,520
+22,916
+0.6% +$365K
UBA
680
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$66.5M 0.01%
2,684,612
-17,278
-0.6% -$373K
PHH
681
DELISTED
PHH Corporation
PHH
$66.3M 0.01%
4,980,157
-797,510
-14% -$10.3M
KNGT
682
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
$66.2M 0.01%
2,491,491
-15,201
-0.6% -$404K
HI
683
DELISTED
Hillenbrand
HI
$66M 0.01%
2,196,560
-68,090
-3% -$2.06M
TRV icon
684
Travelers Companies
TRV
$77.2B
$65.6M 0.01%
551,291
-3,897
-0.7% -$441K
SCU
685
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$65.4M 0.01%
1,721,975
+135,671
+9% +$5.28M
NBHC icon
686
National Bank Holdings
NBHC
$1.92B
$65M 0.01%
3,192,839
-30,048
-0.9% -$612K
SIG icon
687
Signet Jewelers
SIG
$3.59B
$64.5M 0.01%
782,756
+514,971
+192% +$52.3M
MMYT icon
688
MakeMyTrip
MMYT
$5.67B
$64.5M 0.01%
4,339,926
+262,632
+6% +$4.38M
OII icon
689
Oceaneering
OII
$5.08B
$64.5M 0.01%
2,158,638
+46,008
+2% +$1.5M
SWK icon
690
Stanley Black & Decker
SWK
$15.5B
$64.3M 0.01%
578,426
-6,560
-1% -$729K
BATS
691
DELISTED
Bats Global Markets, Inc.
BATS
$64M 0.01%
+2,491,746
New +$63.7M
COF icon
692
Capital One
COF
$136B
$63.3M 0.01%
996,518
-22,340
-2% -$1.56M
KTWO
693
DELISTED
K2M Group Holdings, Inc
KTWO
$63.1M 0.01%
4,065,250
+1,304,060
+47% +$18.4M
SSYS icon
694
Stratasys
SSYS
$767M
$63.1M 0.01%
2,754,972
-7,100
-0.3% -$166K
FNSR
695
DELISTED
Finisar Corp
FNSR
$62.9M 0.01%
3,590,925
-3,455,445
-49% -$59M
CIEN icon
696
Ciena
CIEN
$61.2B
$62.5M 0.01%
3,332,943
+544,698
+20% +$9.86M
TFC icon
697
Truist Financial
TFC
$64.3B
$62.5M 0.01%
1,754,810
+85,510
+5% +$2.99M
KMI icon
698
Kinder Morgan
KMI
$70.7B
$62.4M 0.01%
3,331,826
-13,300
-0.4% -$237K
CDR
699
DELISTED
Cedar Realty Trust, Inc
CDR
$61.8M 0.01%
1,260,568
-1,173
-0.1% -$54.3K
EW icon
700
Edwards Lifesciences
EW
$53.6B
$61.8M 0.01%
1,858,320
+34,140
+2% +$1.17M

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.